Company
Now Is A Good Time To Buy Keros Therapeutics Inc (NASDAQ: KROS)
During the last session, Keros Therapeutics Inc (NASDAQ:KROS)’s traded shares were 1.0 million, with the beta value of the company hitting 1.35. At the end
During the last session, Keros Therapeutics Inc (NASDAQ:KROS)’s traded shares were 1.0 million, with the beta value of the company hitting 1.35. At the end
In last trading session, Keros Therapeutics Inc (NASDAQ:KROS) saw 1.22 million shares changing hands with its beta currently measuring 1.16. Company’s recent per share price
In last trading session, Keros Therapeutics Inc (NASDAQ:KROS) saw 0.57 million shares changing hands with its beta currently measuring 1.32. Company’s recent per share price
© 2024, Powered by Smart TechOne